Table 1.
Comparisons of survival curves
| (A) Both combination therapy and monotherapy with either G47Δ or iDCs enhanced survival as measured by log-rank (Mantel-Cox) analyses | |
|---|---|
| Treatment group vs mock | P* |
| G47Δ + iDC | <0.0001 |
| G47Δ | 0.002 |
| iDC | 0.002 |
|
(B) Combination therapy with G47Δ and iDCs significantly enhanced survival relative to monotherapy with either agent | |
| Treatment group comparisons | Hazard ratio (95% confidence interval) |
|
| |
| G47Δ vs G47Δ + iDC | 9.483 (1.254–71.2) |
| iDC vs G47Δ + iDC | 13.56 (2.792–65.88) |
*
P < 0.017, Bonferroni adjustment for multiple comparisons.